BioElectronics Corp's, CEO Andrew Whelan, New Pain Relief Product Gets FDA Approval

Feb 22, 2017, 02:00 PM

Andrew Whelan, CEO of BioElectronics Corp. (BIEL), returns to the show with Everett Jolly and they discusses their new FDA approved, non-perscription device for pain relief now on the market.

Visit for more interviews and the latest penny stock news

We are pleased to share the following UPTICK Network Stock Day Radio Show and Podcast content. The CEOs interviewed on Stock Day did not incur any charges for their time with Uptick CEO Everett Jolly. Uptick staff is always looking for exciting companies to bring to our interested readers and listeners. Contact us at (602) 441-3474 if you would like further information on the UPTICK Network or Uptick services.